These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 20123141)
1. Questionnaire survey about the motives of commercial livestock farmers and hobby holders to vaccinate their animals against Bluetongue virus serotype 8 in 2008-2009 in the Netherlands. Elbers AR; de Koeijer AA; Scolamacchia F; van Rijn PA Vaccine; 2010 Mar; 28(13):2473-81. PubMed ID: 20123141 [TBL] [Abstract][Full Text] [Related]
2. Why German farmers have their animals vaccinated against Bluetongue virus serotype 8: results of a questionnaire survey. Gethmann J; Zilow V; Probst C; Elbers AR; Conraths FJ Vaccine; 2015 Jan; 33(1):214-21. PubMed ID: 25454856 [TBL] [Abstract][Full Text] [Related]
3. Vaccines against bluetongue in Europe. Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305 [TBL] [Abstract][Full Text] [Related]
5. Expected utility of voluntary vaccination in the middle of an emergent Bluetongue virus serotype 8 epidemic: a decision analysis parameterized for Dutch circumstances. Sok J; Hogeveen H; Elbers AR; Velthuis AG; Oude Lansink AG Prev Vet Med; 2014 Aug; 115(3-4):75-87. PubMed ID: 24768508 [TBL] [Abstract][Full Text] [Related]
6. The epidemiology and diagnosis of bluetongue with particular reference to Corsica. Breard E; Hamblin C; Hammoumi S; Sailleau C; Dauphin G; Zientara S Res Vet Sci; 2004 Aug; 77(1):1-8. PubMed ID: 15120946 [TBL] [Abstract][Full Text] [Related]
7. [Vaccination against bluetongue serotype 8 in the Netherlands]. Kuijk H; Jansen M; Moulin V; Makoschey B Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439 [No Abstract] [Full Text] [Related]
8. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe. Mintiens K; Méroc E; Mellor PS; Staubach C; Gerbier G; Elbers AR; Hendrickx G; De Clercq K Prev Vet Med; 2008 Oct; 87(1-2):131-44. PubMed ID: 18667252 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats. Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877 [TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16. Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822 [TBL] [Abstract][Full Text] [Related]
11. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335 [TBL] [Abstract][Full Text] [Related]
13. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines. Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568 [TBL] [Abstract][Full Text] [Related]
14. [A lot of interest in blue tongue vaccination]. Haneveld JK Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):622-3. PubMed ID: 18767305 [No Abstract] [Full Text] [Related]
15. Financial evaluation of different vaccination strategies for controlling the bluetongue virus serotype 8 epidemic in The Netherlands in 2008. Velthuis AG; Mourits MC; Saatkamp HW; de Koeijer AA; Elbers AR PLoS One; 2011 May; 6(5):e19612. PubMed ID: 21573195 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost-benefit study to encourage herd owners in a cost sharing vaccination programme against bluetongue serotype-8 in Belgium. Cargnel M; Van der Stede Y; Haegeman A; De Leeuw I; De Clercq K; Méroc E; Welby S Transbound Emerg Dis; 2019 Jan; 66(1):400-411. PubMed ID: 30281942 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189 [TBL] [Abstract][Full Text] [Related]
18. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers. van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846 [TBL] [Abstract][Full Text] [Related]
19. Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands. Elbers AR; Backx A; Meroc E; Gerbier G; Staubach C; Hendrickx G; van der Spek A; Mintiens K Prev Vet Med; 2008 Oct; 87(1-2):21-30. PubMed ID: 18620767 [TBL] [Abstract][Full Text] [Related]
20. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]